Chuyển sang chế độ ngoại tuyến với ứng dụng Player FM !
Evaluating Hematuria
Manage episode 301168752 series 1324703
Guest: Aaron M. Potretzke, M.D. (@potretzke)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Microscopic hematuria, and less commonly gross hematuria, are conditions commonly seen by the primary care provider. Malignancy is the most ominous cause of hematuria. Fortunately, other causes are much more likely. Since this is a relatively common health condition, when should we investigate hematuria and what should the evaluation consist of? How do we evaluate a patient’s risk for urinary tract malignancy? Dr. Aaron Potretzke, a urologist at Mayo Clinic joins us to discuss these questions.
Specific topics:
- Definition of hematuria
- Benign causes of hematuria
- Risk of malignancy in low, medium, and high-risk patients
- Stratifying malignancy risk in patients for genitourinary malignancy
- Recommended evaluation for patients with hematuria
- How to manage patients with persistent hematuria despite a negative evaluation
- Role of urine cytology in the evaluation of hematuria
Additional resources:
- American Urological Association hematuria guideline and algorithm: https://www.auanet.org/guidelines/guidelines/microhematuria
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
531 tập
Manage episode 301168752 series 1324703
Guest: Aaron M. Potretzke, M.D. (@potretzke)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Microscopic hematuria, and less commonly gross hematuria, are conditions commonly seen by the primary care provider. Malignancy is the most ominous cause of hematuria. Fortunately, other causes are much more likely. Since this is a relatively common health condition, when should we investigate hematuria and what should the evaluation consist of? How do we evaluate a patient’s risk for urinary tract malignancy? Dr. Aaron Potretzke, a urologist at Mayo Clinic joins us to discuss these questions.
Specific topics:
- Definition of hematuria
- Benign causes of hematuria
- Risk of malignancy in low, medium, and high-risk patients
- Stratifying malignancy risk in patients for genitourinary malignancy
- Recommended evaluation for patients with hematuria
- How to manage patients with persistent hematuria despite a negative evaluation
- Role of urine cytology in the evaluation of hematuria
Additional resources:
- American Urological Association hematuria guideline and algorithm: https://www.auanet.org/guidelines/guidelines/microhematuria
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
531 tập
Tất cả các tập
×Chào mừng bạn đến với Player FM!
Player FM đang quét trang web để tìm các podcast chất lượng cao cho bạn thưởng thức ngay bây giờ. Đây là ứng dụng podcast tốt nhất và hoạt động trên Android, iPhone và web. Đăng ký để đồng bộ các theo dõi trên tất cả thiết bị.